Tag: DNA
CORE Diagnostics to market CellMax Life’s non-invasive cancer test in India
The personalized, precision cancer risk assessment and screening test for cancer that is non-invasive in nature, is being brought to India by Core Diagnostics...............
Crop varieties released by ICAR after 2011 be promoted in India:...
Pre-Kharif Interface by the experts from various top agriculture organizations recommended the DNA fingerprinting of all the released varieties to ascertain their varietal identity and genetic purity.....
AstraZeneca wins ‘Corporate CSR Best Practices Award’
Besides getting honored at the 20th NHRD National Conference, the company was also a finalist in the HR Best Practices category.....
Global biotech market expected to register 12.3% growth by 2020
In countries like China, U.S., and India there is a huge demand for food products such as rice, wheat, beans, and sugarcane, due to the alarming....
New pika species identified by NCBS plays peek-a-boo in Sikkim Himalaya
A new study based on genetic data and skull measurements by the National Centre for Biological Sciences (NCBS), has identified a new species.....
Revolutionary alternative to unnecessary invasive prenatal screening tests
Is it time for India to use the latest technology developments to help prevent pregnant women from undergoing unnecessary invasive prenatal....
Digital PCR-a disruptive technology for nucleic acid replication
With a higher degree of accuracy and reproducibility in the amplification and analysis of nucleic acids like DNA, RNA and cDNA, this technology....i
Biocon registers strong performance, profits up by 17%
Biocon in the first quarter of the financial year 2016-17, has reported the revenues of Rs 952 crore; net profit up by 17 percent at Rs 147 crore ....
Synthetic Biology Opportunity and the Responsible Futures
The ever changing dynamics in the genetic engineering have popped up the term ‘responsible innovation’ which means equal attention to societal needs as well as ethics, write India’s top experts ...
Paradigm & CORE Diagnostics announce exclusive PCDx Tumor Profiling service agreement
PCDx is a comprehensive clinical-grade NGS-based test that is designed to provide physicians....